The Global Health Observatory
Explore a world of health data
Appears in:
- HIV|
© WHO / Petterik Wiggers
Situation and trends
At the end of 2024, 77% [62–90%] of people living with HIV were accessing antiretroviral therapy, up from 24% [19–28%] in 2010.
- Globally, there were 1.1 million [910 000–1.3 million] pregnant women with HIV in 2024, of which an estimated 84% [72–>98%] received antiretroviral drugs to prevent mother-to-child transmission.
- At the end of 2024, there were 1.4 million [1.1–1.8 million] children aged 0–14 years living with HIV globally, down from 2.7 million [2.2–3.4 million] in 2010.
Related indicators
HIV, testing and counselling
HIV response: Antiretroviral therapy coverage
HIV - Prevention of mother-to-child transmission
-
HIV – Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission -
HIV – Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission -
HIV – Estimated number of pregnant women living with HIV
HIV, Pediatric antiretroviral therapy coverage